- Immunoglobulin replacement therapy in the Czech Republic: end-of-year 2020 data from the National registry of primary immunodeficiencies2022 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Relevance of the autoantibodies detection in patients on immunoglobulin replacement therapy2022 | Second Faculty of Medicine, First Faculty of Medicine
- Content and specificity of the Anti-SARS-CoV-2 antibodies in solutions for immunoglobulin replacement therapy2023 | Second Faculty of Medicine
- New possibilities and perspectives of immunoglobulin therapy2016 | Second Faculty of Medicine
- A Multi-Center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency2022 | Faculty of Medicine in Hradec Králové
- Czech Hizentra Noninterventional Study With Rapid Push: Efficacy, Safety, Tolerability, and Convenience of Therapy With 20% Subcutaneous Immunoglobulin2019 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- European consensus proposal for immunoglobulin therapies2014 | Second Faculty of Medicine
- Immunoglobulin Deficiencies: The B-Lymphocyte Side of DiGeorge Syndrome2012 | Second Faculty of Medicine
- Article comment: Secondary antibody deficits and the use of intravenous immunoglobulins2020 | Second Faculty of Medicine
- Fifteen Years of the J Project2019 | Second Faculty of Medicine
- High Prevalence of Likely Passively Acquired Anti-TPO and Anti-GAD Autoantibodies in Common Variable Immunodeficiency2022 | Second Faculty of Medicine, First Faculty of Medicine
- X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease2011 | Second Faculty of Medicine
- Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence2021 | Second Faculty of Medicine, First Faculty of Medicine
- Interim Analysis: Open-Label Extension Study of Leniolisib for Patients with APDS2024 | Second Faculty of Medicine